U.S. Physical Therapy, Inc. (USPH)
NYSEHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
$79.35+0.90%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
QuarterlyIQ Insights · USPH
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $79 USPH trades at 31× p/e — 1.3× the 23× p/e peer median. The market is re-rating it beyond its own range; our $54 fair value is medium-confidence here. Even valued only for durable growth at sustainable margins, it's worth about $98 — above today's price, so the premium reflects that growth case, not pure multiple expansion. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| dcf fcfe | 12M | $147.09 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $84.29 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $27.50 | — | — | TTM | high |
| graham number | 12M | $41.27 | — | — | TTM | high |
| Peer EV/EBITDA | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Only expensive valuation — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price you pay about 17% over what the business is worth with no growth; closing that gap needs roughly 3.0 years of the forecast growth to come through. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $3.29/sh owner earnings.
Looks more expensive than peers.
Self-history needs ~20 months of data.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $24.01 |
| 5.6 |
| 7.11 |
| TTM |
| high |
| Peer P/FCF | 12M | $71.79 | 16.9 | 4.25 | TTM | high |
| Peer P/E | 12M | $58.92 | 23.2 | 2.54 | TTM | high |
| Peer P/S | 12M | $57.79 | 1.1 | 53.90 | TTM | high |
| PEG | 12M | $55.77 | 22.0 | 2.54 | TTM | high |
| residual income | 12M | $30.39 | — | — | TTM | high |
| triangulated | 12M | $61.66 | 23.2 | 2.66 | Triangulated | high |
| Peer P/FCF | 3Y | $74.66 | 16.9 | 4.42 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $91.02 | 23.2 | 3.92 | Analyst | medium |
| Peer P/S | 3Y | $75.23 | 1.1 | 70.16 | Analyst | medium |
| PEG | 3Y | $86.15 | 22.0 | 3.92 | Analyst | medium |
| Peer P/FCF | 5Y | $76.64 | 16.9 | 4.54 | Hist. CAGR(prov.) | medium |
| Peer P/E | 5Y | $108.07 | 23.2 | 4.66 | Analyst | medium |
| Peer P/S | 5Y | $89.31 | 1.1 | 83.29 | Analyst | medium |
| PEG | 5Y | $102.28 | 22.0 | 4.66 | Analyst | medium |